Government
The U.S. Food and Drug Administration (FDA)’s Circulatory System Devices Panel is in the middle of two days of presentations and meetings regarding mortality rates associated with the use of paclitaxel-coated balloons (DCBs) and paclitaxel-eluting stents (DESs). The discussions are noting missing data and conflicting analysis.
Scientists from the Agency for Science, Technology and Research’s Genome Institute of Singapore have identified two new Epstein-Barr Virus viral variants associated with cancers, including nasopharyngeal carcinoma, gastric cancer, and several kinds of lymphomas[2].
Transparency in clinical trials has been a concern and the new study highlights the continued issue.
In light of the Center for Disease Control and Prevention’s guidelines for safe cold chain vaccine storage, pharmacies have an increasing need for electronic temperature monitoring and alarming.
The lawsuit was joined by Merck, Eli Lilly and Amgen. The companies claim the Department of Health and Human Services does not have the legal authority to force the companies to comply with the new rule.
June is turning out to be a busy month for approvals for the U.S. Food and Drug Administration. The agency has a slate of PDUFA dates this week, including two for Merck alone. Here’s a look.
The stool sample used in the experimental procedure was not properly tested, the FDA said.
The pilot program aims to develop an electronic system to identify and trace certain prescription drugs as they are distributed within the United States.
Efforts undertaken by state and local leaders across the five states that make up Pharm Country have led to a boost in business, which is good news for applicants seeking a new position.
The International Biofilm Summit, addressing the main threat to food contamination, seizes the opportunity of its third edition on 23-24 October to take it to the next level.
PRESS RELEASES